To better recognise its potential to address the challenge of white space in clinical trials, it helps to first understand ...

For the Financial Times (FT) Global Pharma & Biotech Summit in London 2025, pharmaphorum is providing coverage courtesy ...

"By combining precise tumour targeting with an immunotherapy payload, Daiichi Sankyo is exploring a new way to harness the ...

The $6.7 billion merger brought together two companies that had been forced to file for bankruptcy protection due to opioid ...

The LEGEND trial showed a 62% complete response (CR) rate with the non-viral gene therapy at six months in NMIBC patients who ...

Li also explains how progress in precision oncology depends on close collaboration between pharma and diagnostic developers, ...

Eli Lilly has enlisted the aid of Tan France, fashion guru on the wildly popular US makeover show Queer Eye, in a campaign ...

The LDL-C reductions seen with enlicitide in both studies are in the same ballpark as those seen with injectable ...

The curious finding was revealed at the American Heart Association (AHA) annual congress in New Orleans over the weekend, and ...

According to the White House, Novo Nordisk's semaglutide-based Ozempic for diabetes and Wegovy for obesity will cost $350 per ...

The US regulator has cleared Caplyta (lumateperone) as an adjunctive therapy with antidepressants for the treatment of major ...

Roche has built the evidence for its oral BTK inhibitor fenebrutinib in multiple sclerosis (MS) with two phase 3 readouts ...